Catalyst Wire Dossier Catalyst Wire Dossier

Loteprednol Etabonate Ophthalmic Gel 0.5%

loteprednol etabonate · Bausch & Lomb Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Loteprednol Etabonate Ophthalmic Gel 0.5%, covering 2013-11-08 to 2013-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation [Phase 1]

See pricing